Lentiviral FVIII Gene Therapy
Clinical trial NCT03217032 · RECRUITING
Trial details
- NCT number
- NCT03217032
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-05-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.